Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Nov 28;37(50):7328-7335.
doi: 10.1016/j.vaccine.2017.03.076. Epub 2017 Apr 7.

The rotavirus vaccine development pipeline

Carl D Kirkwood  1 , Lyou-Fu Ma  2 , Megan E Carey  2 , A Duncan Steele  2
Affiliations
Review

The rotavirus vaccine development pipeline

Carl D Kirkwood et al. Vaccine. .

Abstract

Rotavirus disease is a leading global cause of mortality and morbidity in children under 5years of age. The effectiveness of the two globally used oral rotavirus vaccines quickly became apparent when introduced into both developed and developing countries, with significant reductions in rotavirus-associated mortality and hospitalizations. However, the effectiveness and impact of the vaccines is reduced in developing country settings, where the burden and mortality is highest. New rotavirus vaccines, including live oral rotavirus candidates and non-replicating approaches continue to be developed, with the major aim to improve the global supply of rotavirus vaccines and for local implementation, and to improve vaccine effectiveness in developing settings. This review provides an overview of the new rotavirus vaccines in development by developing country manufacturers and provides a rationale why newer candidates continue to be explored. It describes the new live oral rotavirus vaccine candidates as well as the non-replicating rotavirus vaccines that are furthest along in development.

Keywords: Non-replicating; Rotavirus; Vaccines.

PubMed Disclaimer

Figures

None
Graphical abstract
See this image and copyright information in PMC

References

    1. GBD 2015 lancet GBD 2015 mortality and causes of death collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the global burden of disease study 2015. Lancet 2016; 388: 1459–544. - PMC - PubMed
    1. Kotloff K.L., Nataro J.P., Blackwelder W.C., Nasrin D., Farag T., Panchalingam S. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the global multicenter study, GEMS): a prospective, case control study. Lancet. 2013;382:209–222. - PubMed
    1. Liu J., Platts-Mills J.A., Juma J., Kabir F., Nkeze J., Okoi C. Use of quantitative molecular diagnostic methods to identify causes of diarrehoea in young children: a re-analysis of the GEMS case control study. Lancet. 2016;388:1291–1301. - PMC - PubMed
    1. Parashar U.D., Hummelman E.G., Bresee J.S., Miller M.A., Glass R.I. Global illness and deaths caused by rotavirus disease in children. Emerging Infect Dis. 2003;9:565–572. - PMC - PubMed
    1. Tate J.E., Burton A.H., Boschi-Pinto C., Parashar U.D. World health organization-coordinated global rotavirus surveillance network. Global, regional, and national estimates of rotavirus mortality in children <5 years of age, 2000–2013. Clin Infect Dis. 2016;62:S96–S105. - PMC - PubMed

Substances